Tenoxicam
From Wikipedia, the free encyclopedia
 |
|
|
Tenoxicam
|
|
| Systematic (IUPAC) name | |
| (3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxothieno[2,3-e]thiazin-4-one | |
| Identifiers | |
| CAS number | ? |
| ATC code | M01 |
| PubChem | |
| Chemical data | |
| Formula | C13H11N3O4S2 |
| Mol. mass | 337.376 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Tenoxicam is a non-steroidal anti-inflammatory drug. It is manufactured by Roche under the tradename Mobiflex. It is available in the 
United Kingdom as a prescription-only drug.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||||||||||||||||
